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INTRODUCTION
Haemophilus influenzae is one of the leading bacterial agents, causing community-acquired invasive and respiratory diseases in both children and adults.
New H. influenzae type b conjugate vaccine (Hib) is now available. Bulgarian Ministry of Health decided to introduce vaccination against Hib disease in our childhood vaccination schedule starting in April 2010.
The aims of this study were: 1. To determine different capsular types by PCR genotyping of H. influenzae strains isolated from children and adults with invasive and respiratory diseases before the introduction of Hib conjugate vaccine in our country.
2. To study the microbiological features of the collected isolates: beta-lactamase production; biotypes and other clinical parameters.
MATERIALS AND METHODS
Bacterial isolates. A total of 175 H. influenzae strains were collected between 1994 and 2009 from all aged groups. They were isolated from cerebrospinal fluid (CSF) (n=53), blood (n=8), sputum (n=60), ear fluid (n=8) and upper respiratory tract (URT) (n=46). Patients from whom the strains were isolated had meningitis, septicemia or community-acquired respiratory tract infections (otitis media in children, pneumonia, bronchitis, conjunctivitis or acute exacerbations of chronic obstructive pulmonary disease in adults).
All strains were identified according to the standard microbiological methods [4] . Beta-lactamase production was determined by the chromogenic cephalosporin test with nitrocephin as substrate (Cefinase, BBL, BD).
Serotyping of H.influenzae. The strains were serotyped by a coagglutination test (Phadebact Haemophilus test; Bactus AB, Huddinge, Sweden) and by molecular PCR capsular typing method.
DNA isolation. DNA isolation was performed from a 24-hour culture on chocolate agar containing 1% isovitalex. One loopful of each bacterial culture was suspended in 400 µl of sterile distilled water and then boiled for 3 min. The boiling extract was centrifuged at 12,000 x g for 10 min. The supernatant was then collected.
PCR of capsular genes. The genes were amplified with primer sets by Falla et al. [2] and listed in Table 1 . PCR was implemented by using 2.5 µl of template DNA, 1 µM of each primer, 0.2 mM deoxyribonucleotides, 1 x reaction buffer, 2 mM MgCl2 and 0,5 U of Taq polymerase in a total volume of 25 µl. The DNA was amplified using the following protocol: initial denaturation (94°C for 5 min), followed by 25 cycles of denaturation (94°C for 1 min), annealing (60°C for 1 min), and extension (72°C for 1 min). After the final cycle there was a single final extension of 10 min at 72°C. 10 µl of PCR products were separated for 30 min at 130 V in 1% agarose in Tris-Clborate-EDTA buffer and visualized by ethidium bromide staining (0.5 ìg/ml). The size of the amplified products was compared with a positive control, obtained from CDC, Atlanta, USA. The detection was performed by UV transillumination (wavelength 312 nm). 
RESULTS AND DISCUSSION
Taking in consideration the specimens' source of isolates and the patients' age, it was obvious that the meningitis and other invasive diseases were the most common (91.8%) in children less than 5 years of age (56 out of 61 cases) and they were caused predominantly by serotype b of H. influenzae (95.1%).
Alternatively, in respiratory tract infections (RTI-114 cases), 39.5% of the isolates were from children under the age of 5 years and 48.2% were from adult patients. (Fig. 1) Serotype PCR determination was performed in two steps and it characterized all 175 H. influenzae strains as follows: 61 (34.9%) strains were type b, 1 (0.6%) isolate type f, and the rest 113 (64.6%) strains were non-capsulated or nontypeable H. influenzae (NTHi). (Fig. 2) The first set of primers (HI1 and HI2) amplified a 343 bp product only from the 62 capsulate strains (Fig. 3) . All the others, previously serotyped by the coagglutination test, were negative for the capsular expression gene (bexA) and hence, non-capsulated. The second set of primers (b1 and b2) used, revealed a 480 bp product from all the capsulate strains but one (Fig. 4) . They were clearly confirmed as H. influenzae type b, possessing duplicated capB locus. The second primers' set was also used to verify whether all NC strains are really lacking capsular genes or amongst these there are so called mutant b¯ strains. These strains are indistinguishable from NC strains by traditional serotyping techniques but can be determined by the PCR method. As a result of losing one of the copies of the cap gene and the bexA gene they fail to produce and express a capsule. They can be detected after amplification with b1 and b2 primers, producing type b-specific product. All the 113 strains which failed to produce product with HI-1 and HI-2, were also negative with b1 and b2 which excluded the presence of capsule-deficient mutants among the isolates.
There was a total match between the coagglutination test and the PCR method for serotyping of H. influenzae. But PCR capsular genotyping was more useful to distinguish different capsular serotypes (one of type f) and capsuledeficient mutants of type b strains -b-strains (none was found in this study).
Serotype distribution in patients with RTI from all age groups showed that NTHi strains were the most commonly found isolates -96.5%. Only two strains isolated from mucosal respiratory infections were type b (2.6%) and 1 was type f (0.9%). (Fig. 5) Overall, beta-lactamase production was detected in 19.4% of the 175 tested H. influenzae strains. â-lactamase production was higher in children with meningitis (37.7%) and otitis media (37.5%), but it was less in mucosal respiratory isolates (2.3%) and sputum (13.3%) in both age groups children and adults. (Fig. 6) Beta-lactamase production in Hib strains has not changed over the last 15 years in children with meningitis [3] . 
